Peregrine adds to coffers

AuntMinnie.com staff writers
Jun 23, 2005

Peregrine Pharmaceuticals has inked a definitive agreement to sell 8 million shares of common stock to an institutional investor for net proceeds of $6.7 million.

The funding will be used to advance Peregrine's three clinical trials, as well as support other preclinical studies, according to the Tustin, CA-based firm.

By AuntMinnie.com staff writers
June 24, 2005

Related Reading

Peregrine nets grant from Philip Morris, September 9, 2003

TNT gets clearance in China, August 13, 2003

Peregrine, Affitech team up, June 18, 2003

Peregrine regains Nasdaq compliance, June 12, 2003

Peregrine, Schering team up, January 7, 2003

Copyright © 2005 AuntMinnie.com

Latest in Clinical News
2024 04 19 7 Year Old Boy With Autoimmune Sclerosing Cholangitis
MR elastography effective for assessing liver stiffness in children
April 19, 2024
Breast Mammography Scanner
High breast density tied to impaired recurrence-free cancer survival
April 19, 2024
My BreastAI Suite by GE HealthCare
Sponsored
My BreastAI Suite by GE HealthCare
April 2, 2024
Tspo Thumbnail
PET/MRI reveals sex differences in patients with autism
April 18, 2024
Related Stories
2005 06 23 15 59 46 706
MRI
4D MRI enables blood-velocity measurement in mitral valve insufficiency
2005 06 21 15 03 29 706
Breast
PET mammography unit shows promise for DCIS
2005 06 20 15 36 30 706
Nuclear Medicine
3D rendering captures SNM's Image of the Year
We care about what you think.
Sponsor Content
We care about what you think.
More in Clinical News
MR elastography effective for assessing liver stiffness in children
By Kate Madden Yee
MR elastography is an effective technique for noninvasive monitoring of liver stiffness -- a surrogate for fibrosis -- in children and young adults with autoimmune liver disease, researchers have reported.
April 19, 2024
2024 04 19 7 Year Old Boy With Autoimmune Sclerosing Cholangitis
High breast density tied to impaired recurrence-free cancer survival
By Amerigo Allegretto
Recurrence-free breast cancer survival is less likely in women with high breast density compared with women with low density.
April 19, 2024
Breast Mammography Scanner
Can ChatGPT ‘data mine’ patient reports for stroke registries?
By Will Morton
ChatGPT-4 appears useful for extracting details from reports on thrombectomy procedures in stroke patients, a labor-intensive and error-prone task currently performed by human readers.
April 19, 2024
Stroke Skull Xray 400
PET/MRI reveals sex differences in patients with autism
By Will Morton
PET/MRI shows that young women with autism spectrum disorder have increased brain metabolism associated with translocator protein.
April 18, 2024
Tspo Thumbnail
Radiologist consultation improves patients' LCS attitudes
By Kate Madden Yee
Consulting with a radiologist boosts patients' attitudes toward lung cancer screening (LCS) and their interest in quitting smoking, researchers have reported.
April 18, 2024
Doctor Female Young Desk 400
PET tracer for gliomas under expedited review
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to Telix Pharmaceuticals’ PET radiotracer F-18 floretyrosine (Pixclara) for imaging progressive or recurring gliomas.
April 17, 2024
Gliomas
AI proposed to help radiologists detect child abuse injuries
By Will Morton
A team at Michigan State University has developed an AI model designed to detect rib fractures in children under 3 years old.
April 17, 2024
Test set images with ground truth (teal, red) and model predictions (green, yellow), with true positives (green), false positives (yellow), and false negatives (red). Predictions from the 6x-YOLOv5 ensemble trained on histogram equalized input images with a y = 0.2 avalanche scheme, achieving 0.536 precision, 0.795 recall, and 0.723 F2 score. Image and caption courtesy of Scientific Reports.
Tailored lung cancer screening model helps determine nodule follow-up
By Kate Madden Yee
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT helps clinicians determine how to follow up better than rule-based protocols, researchers have found.
April 17, 2024
Lung Cancer
POCUS used widely in lung ultrasound applications
By Amerigo Allegretto
Some of the top domains for users of point-of-care ultrasound (POCUS) incorporate the technology for lung ultrasound applications.
April 17, 2024
Screenshot (1142)
CT-based deep learning identifies patients at further lung cancer risk
By Kate Madden Yee
A CT-based deep learning model can identify individuals with clinical stage IA non-small cell lung cancer (NSCLC) at high risk of further disease, researchers have found.
April 16, 2024
Ai
Deep-learning model determines breast tumor staging
By Amerigo Allegretto
A deep-learning model based on mammographic images can determine tumor staging and sentinel lymph node metastasis in breast cancer patients.
April 16, 2024
Researchers explain the data preparation and structure of a proposed CNN-based deep learning model using mammography features to determine breast tumor staging. The image is available for use under a Creative Commons license: CC BY-NC-ND 4.0 DEED Attribution-NonCommercial-NoDerivs 4.0 International.
FAPI-PET shows promise in patients with lung cancer
By Will Morton
FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans.
April 15, 2024
F-18 FDG and Ga-68 FAPI-46 images of a 51-year-old woman with adenocarcinoma with lepidic growth pattern in right upper lobe. (A) Maximum-intensity-projection PET images. The lesion had F-18 FDG uptake below blood pool level but was strongly Ga-68 FAPI-46-positive. CT-guided biopsy led to pathologic diagnosis of adenocarcinoma, and the patient was treated by stereotactic body radiation therapy because of functional inoperability. Image courtesy of the Journal of Nuclear Medicine.
Page 1 of 3587
Next Page